We plan to use these techniques to design and
test effective treatments for these diseases.
Not exact matches
«We have
effective screening
tests for several cancers, which allow physicians and other health - care providers to identify the
disease at an earlier stage — often before symptoms surface — when
treatment is more likely to result in a cure,» said senior author of the report and IPHI Director Kenneth W. Kizer.
Although there remains no cure
for Alzheimer's, researchers hope that
testing potential drugs or therapies prior to mental decline will prove to be more successful than previous attempts at finding the most
effective treatment in the battle against the debilitating
disease.
«We urgently need markers to predict which therapies are going to be
effective and which will not be
effective in individual patients with advanced prostate cancer,» said lead study author Emmanuel Antonarakis, MD, an assistant professor of oncology and urology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Md. «AR - V7
testing may be extremely valuable in guiding
treatment decisions
for men with hormone - resistant
disease in the near future.»
Although this type of analysis is less likely to be easily translated to the clinic, it could be very
effective for clinical trials, as so many of the current
tests for progression of Parkinson's
disease and impact of
treatments are very subjective and not sensitive to changes in clinical state.»
An important step in developing
effective treatments for human
disease is finding an
effective animal model of the
disease to
test potential therapies.
Any (1) condition
for which medical advice, diagnosis, care, or
treatment (includes receiving services and supplies, consultations, diagnostic
tests or prescription medicines) was recommended or received during the 18 months immediately preceding the Certificate
Effective Date; (2) condition that had manifested itself in such a manner that would have caused a reasonably prudent person to seek medical advice, diagnosis, care, or
treatment (includes receiving services and supplies, consultations, diagnostic
tests or prescription medicines) within the 18 months immediately preceding the Certificate
Effective Date; (3) injury, illness, sickness,
disease, or other physical, medical, mental, or nervous conditions, disorder or ailment (whether known or unknown) that, with reasonable medical certainty, existed at the time of application or within the 18 months immediately preceding the Certificate
Effective Date.
Treatment (s) which is incurred by an Insured Person (s) who is HIV Positive (i.e., infected with the human immunodeficiency virus, the cause of acquired immunodeficiency syndrome) at the time of Application
for this Insurance, whether or not the Insured Person (s) was asymptomatic or symptomatic or had knowledge of his / her HIV status on the initial
Effective Date of Coverage, or any associated diagnostic
tests or charges
for HIV infection, seropositivity to the AIDS virus, AIDS related Illness (es), ARC Syndrome, AIDS, and all
diseases caused by and / or related to HIV;
A Pre-Existing Condition is defined as, «Any (1) condition
for which medical advice, diagnosis, care, or
treatment (includes receiving services and supplies, consultations, diagnostic
tests or prescription medicines) was recommended or received... immediately preceding the Certificate
Effective Date; (2) condition that had manifested itself in such a manner that would have caused a reasonably prudent person to seek medical advice, diagnosis, care, or
treatment (includes receiving services and supplies, consultations, diagnostic
tests or prescription medicines)... immediately preceding the Certificate
Effective Date; (3) injury, illness, sickness,
disease, or other physical, medical, mental, or nervous conditions, disorder or ailment (whether known or unknown) that, with reasonable medical certainty, existed at the time of application or... immediately preceding the Certificate
Effective Date.»
``... these cuts will disenfranchise a segment of the population and lead to increased non-compliance with their doctor's requests
for pathology
testing due to the requirement of a co-payment... including: delaying the
effective early diagnosis of cancer leading to premature deaths; compromising the
effective treatment of diabetes and chronic
diseases; and threatening the services of rural pathology» (Dr Michael Harrison RCPA).